3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
7
Surgical Wound Infection
5
Pilonidal Sinus
3
Wound Infection
2
Sarcoma
2
Thyroid Nodule
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Spinal Cord Injuries
1
Skin Neoplasms
1
Skin Carcinoma
1
Seroma
1
Postoperative Complications
1
Obesity
1
Non-melanoma Skin Cancer
1
Neoplasm Metastasis
1
Infections
1
Graves Disease
1
Goiter
1
Esophageal Neoplasms
1
Anastomotic Leak
1
Adenocarcinoma
1
Interventions
Nivolumab
13
Ipilimumab
10
pembrolizumab
8
cemiplimab
6
Surveys and Questionnaires
6
Biopsy
6
aldesleukin
5
Radiotherapy
5
Interleukin-2
5
Blood Specimen Collection
5
Temozolomide
4
Sirolimus
4
Photochemotherapy
4
Mohs Surgery
4
HhAntag691
4
Fluorouracil
4
Educational Status
4
Cyclophosphamide
4
sonidegib
3
fludarabine phosphate
3
fludarabine
3
avelumab
3
Vemurafenib
3
Surgical Procedures, Operative
3
Radiation
3
Petrolatum
3
Cetuximab
3
Aminolevulinic Acid
3
trametinib
2
dabrafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Skin Neoplasms
×
Negative-Pressure Wound Therapy
×
Clear all
NCT07040683
2026-05-28
LEGS
Region Skane
Phase NA
Recruiting
242 enrolled